+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Lysosomal Disease Treatment Market Report 2025 - Product Thumbnail Image

Lysosomal Disease Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hormone Therapy Market Report 2025 - Product Thumbnail Image

Hormone Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pompe Disease Market Report 2025 - Product Thumbnail Image

Pompe Disease Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Facial Palsy Market - Global Forecast 2025-2030 - Product Thumbnail Image

Facial Palsy Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
Anticholinergic Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Anticholinergic Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Neuropathy Pain Treatment Market - Global Forecast 2025-2030 - Product Thumbnail Image

Neuropathy Pain Treatment Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Loading Indicator